Rituximab biosimilar for the treatment of diffuse large B-cell lymphoma: a phase 3 randomized study in India

por Patel, Ankit, Bhatt, Niraj, Prakash, S. S., Biswas, Ghanashyam, Nagarkar, Rajnish, Roy, Bodhisatta, Samal, Priyanka, Agrawal, Narendra, Meshram, Sushil, Kaushal, Ashish, Satheesh, C. T., Wategaonkar, Ravikumar, Thiagarajan, Kasi Viswanathan, Jain, Kartikeya, Vijayaveeran, P., Mukherjee , Kalyan, Singh, Kishore, Patil, Tushar, Jain, Amit, Dolai, Tuphan Kanti, Jain, Minish, Hingmire, Sachin, Gupta, Tara Chand, Lakshmaiah, K. C., Rajamanickam, Deepan, Nemade, Bhushan, Goyal, Vikash, Mahato, Pinaki, Mendiratta, Sanjeev Kumar, Doshi, Maulik
Publicado 2023